Cybin (HELP) Gross Profit (2020 - 2021)

Cybin (HELP) posted Gross Profit of $158019.7 for Q1 2021, up 100.1% on a QoQ basis from -$153.4 million in Q4 2020.

Cybin (HELP) Gross Profit (2020 - 2021) Analysis & Trends

Cybin's Gross Profit history runs 2 years deep, the most recent figure standing at $158019.7 for Q1 2021.

Quarterly Gross Profit changed N/A year-over-year to $158019.7 in Q1 2021, while the trailing twelve-month figure through Mar 2021 was -$9.0 million (changed N/A YoY) and the FY2021 annual result came in at $200.0, changed N/A from the prior year.
Gross Profit was $158019.7 for Q1 2021 at Cybin, up from -$153.4 million in the prior quarter.
Across five years, Gross Profit topped out at $144.2 million in Q2 2020 and bottomed at -$153.4 million in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn
7	Belite Bio	61.40 Bn	61.40 Bn	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn
9	Revolution Medicines	37.37 Bn	37.37 Bn	-
10	Cybin	262.76 Mn	262.76 Mn	-

Download Data